Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients. The company provides products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases. Korea Arlico Pharm Co.,Ltd. was founded in 1992 and is headquartered in Seoul, South Korea.
Metrics to compare | 260660 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship260660PeersSector | |
---|---|---|---|---|
P/E Ratio | −22.1x | 6.4x | −0.5x | |
PEG Ratio | 0.18 | −0.13 | 0.00 | |
Price/Book | 0.9x | 0.8x | 2.6x | |
Price / LTM Sales | 0.3x | 0.7x | 3.3x | |
Upside (Analyst Target) | - | 31.1% | 42.9% | |
Fair Value Upside | Unlock | 25.1% | 6.2% | Unlock |